Australia, Aug. 30 -- Nexsen Biotech Pty. Ltd., owns the trademark (2514207) for 'TESTSURE' till Jan. 21, 2035.
Status: registered:
Registered/protected
Class: 5 [specimen collection kits comprised primarily of swabs for medical purposes; specimen collection kits for use in virus testing consisting primarily of swabs for medical purposes; specimen collection kits comprised primarily of swabs for medical purposes for use in virus testing; reagents for use in diagnostic tests for medical purposes; medical diagnostic reagents and assays for testing of body fluids; diagnostic reagents and assays for detecting antigens for medical purposes; diagnostic kits comprising diagnostic agents, preparations and substances for medical purposes; diagnostic kits comprising diagnostic agents, preparations and substances for medical use; diagnostic test kits for medical or veterinary purposes; diagnostic kits comprising primarily monoclonal antibodies, buffers and reagents for use in disease testing; diagnostic kits comprised of assays for testing of bodily fluids for use in disease detection; diagnostic kits containing primarily monoclonal antibodies, buffers and reagents for use in disease testing; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; diagnostic reagents and preparations for medical use; medical diagnostic test strips; diagnostic test reagents for medical purposes; diagnostic kits comprised of medical diagnostic reagents; diagnostic reagents and contrast media for medical purposes]
Type of Mark: Word
Date of Acceptance: Feb. 10
Registration Advertised: Aug. 29
For further details contact Patenteur Pty. Ltd. .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2514207.
Disclaimer: Curated by HT Syndication.
